CLDX Historical Earnings image   This CLDX historical earnings page last updated 11/14/2022
CLDX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/9/20220.00B
Q2 20228/8/20220.00B
Q1 20225/5/20220.00B
Q4 20212/28/20220.00B
Q3 202111/9/20210.00B
Q2 20218/5/20210.00B
Q1 20215/6/20210.00B
Q4 20203/29/20210.00B
Q3 202011/5/20200.00B
Q2 20208/6/20200.00B
Q1 20205/6/20200.00B
Q4 20193/26/20200.00B
Q3 201911/12/20190.00B
Q2 20198/7/20190.00B
Q1 20195/7/20190.00B
Q4 20183/7/20191.76M
Q3 201811/7/2018941000
Q2 20188/8/20182.76M
Q1 20185/10/20184.07M
Q4 20173/7/20183.46M
Q3 201711/7/20173.92M
Q2 20178/8/20173.83M
Q1 20175/9/20171.53M
Q4 20163/14/20171.87M
Q3 201611/7/20162.22M
Q2 20168/8/20161.39M
Q1 20165/5/20161.30M
Q4 20152/25/20161.79M
Q3 201511/5/20151.03M
Q2 20158/10/20152.18M
Q1 20154/29/2015500000
Q4 20142/24/2015320000
Q3 201411/4/20141.10M
Q2 20148/6/2014592000
Q1 20145/1/2014416000
Q4 20133/3/2014620000
Q3 201311/8/2013980000
Q2 20138/6/201397000
Q1 20135/2/20132.41M
Q4 20123/7/20130.00B
Q3 201211/1/20123.10M
Q2 20128/10/20120.00B
Q1 20125/3/20122.43M
CLDX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/9/2022-0.570
Q2 20228/8/2022-0.770
Q1 20225/5/2022-0.490
Q4 20212/28/2022-0.430
Q3 202111/9/2021-0.370
Q2 20218/5/2021-0.340
Q1 20215/6/2021-0.420
Q4 20203/29/2021-0.550
Q3 202011/5/2020-0.360
Q2 20208/6/2020-0.500
Q1 20205/6/2020-0.730
Q4 20193/26/2020-0.640
Q3 201911/12/2019-0.750
Q2 20198/7/2019-0.840
Q1 20195/7/2019-1.400
Q4 20183/7/2019-0.81
Q3 201811/7/2018-0.600
Q2 20188/8/2018-1.650
Q1 20185/10/2018-12.750
Q4 20173/7/2018-2.550
Q3 201711/7/2017-2.100
Q2 20178/8/2017-3.450
Q1 20175/9/2017-4.200
Q4 20163/14/2017-4.500
Q3 201611/7/2016-4.350
Q2 20168/8/2016-4.800
Q1 20165/5/2016-5.250
Q4 20152/25/2016-4.950
Q3 201511/5/2015-4.800
Q2 20158/10/2015-4.950
Q1 20154/29/2015-4.950
Q4 20142/24/2015-5.400
Q3 201411/4/2014-4.650
Q2 20148/6/2014-4.800
Q1 20145/1/2014-4.950
Q4 20133/3/2014-4.050
Q3 201311/8/2013-4.350
Q2 20138/6/2013-3.600
Q1 20135/2/2013-3.450
Q4 20123/7/2013-4.050
Q3 201211/1/2012-3.750
Q2 20128/10/2012-3.450
Q1 20125/3/2012-4.050
Quotes delayed 20 minutes

Email EnvelopeFree CLDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Celldex Therapeutics (CLDX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CLNN Historical Earnings
CLOV Historical Earnings
CLPT Historical Earnings
CLRB Historical Earnings
CLSD Historical Earnings
CLSN Historical Earnings
CLVS Historical Earnings
CLXT Historical Earnings
CMAX Historical Earnings
CMD Historical Earnings
What was the record high CLDX historical earnings result?
In terms of earnings or revenue, what is the best CLDX historical earnings result that Celldex Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CLDX historical earnings result was set in Q2 2021, when Celldex Therapeutics posted results of -0.340/share. The most successful revenue quarter within our data set was Q1 2018 when Celldex Therapeutics reported revenue of 4.07M.

What was the lowest Celldex Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CLDX has reported, and when?

✔️Accepted answer: Within our data set, the lowest CLDX historical earnings result was set in Q1 2018, when Celldex Therapeutics posted results of -12.750/share. The smallest revenue quarter within our data set was Q2 2013 when Celldex Therapeutics reported revenue of 97000.

On this page we presented the CLDX historical earnings date information for Celldex Therapeutics. Reviewing that CLDX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2021, when CLDX posted gaap of -0.340/share. Meanwhile the lowest CLDX historical earnings result was in Q1 2018, when CLDX posted gaap of -12.750/share. Moving to Celldex Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2018 when CLDX reported 4.07M in revenue, while the smallest revenue quarter was Q2 2013 when CLDX reported 97000 in revenue.

For self directed investors doing their due diligence on CLDX or any other given stock, their research can benefit from looking into all of the Celldex Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Celldex Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CLDX. Thanks for visiting, and the next time you need to research CLDX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: APSA Videos, PTRY Historical Stock Prices, Funds Holding GRVI.

 

CLDX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.